ESTRO 2024 - Abstract Book

S426

Brachytherapy - Urology

ESTRO 2024

14. Crook J, Rodgers JP, Pisansky TM, Trabulsi EJ, Amin MB, Bice W, et al. Salvage Low Dose Rate Prostate Brachytherapy: Clinical Outcomes of a Phase II Trial for Local Recurrence after External Beam Radiotherapy (NRG Oncology/0526). Int J Radiat Oncol Biol Phys. 2022 Apr 1;112(5):1115 – 22.

15. Wu CT, Chen WC, Liao SK, Hsu CL, Lee KD, Chen MF. The radiation response of hormone-resistant prostate cancer induced by long-term hormone therapy. Endocr Relat Cancer. 2007 Sep 1;14(3):633 – 43.

16. Patel KR, Rydzewski NR, Schott E, Cooley-Zgela T, Ning H, Cheng J, et al. A Phase I Trial of Focal Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate Cancer. Pract Radiat Oncol. 2023 Jul;S1879850023001716. 17. Leroy T, Lacornerie T, Bogart E, Nickers P, Lartigau E, Pasquier D. Salvage robotic SBRT for local prostate cancer recurrence after radiotherapy: preliminary results of the Oscar Lambret Center. Radiat Oncol Lond Engl. 2017 Jun 9;12(1):95. 18. D’Agostino GR, Di Brina L, Mancosu P, Franzese C, Iftode C, Franceschini D, et al. Reirradiation of Locally Recurrent Prostate Cancer With Volumetric Modulated Arc Therapy. Int J Radiat Oncol Biol Phys. 2019 Jul 1;104(3):614 – 21. 19. Zerini D, Jereczek-Fossa BA, Fodor C, Bazzani F, Maucieri A, Ronchi S, et al. Salvage image-guided intensity modulated or stereotactic body reirradiation of local recurrence of prostate cancer. Br J Radiol [Internet]. 2015 Aug [cited 2023 Jul 14];88(1052). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4651383/ 20. Bergamin S, Eade T, Kneebone A, Booth J, Hsiao E, Schembri GP, et al. Interim Results of a Prospective Prostate-Specific Membrane Antigen-Directed Focal Stereotactic Reirradiation Trial for Locally Recurrent Prostate Cancer. Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1172 – 8. 21. Rasing MJA, Peters M, Son M van, Moerland MA, Eppinga W, Pol SMG van de, et al. Recurrence characteristics after focal salvage HDR brachytherapy in prostate cancer. Radiother Oncol [Internet]. 2023 Mar 1 [cited 2023 Jul 13];180. Available from: https://www.thegreenjournal.com/article/S0167-8140(23)00033-6/fulltext# 22. Morton G, McGuffin M, Chung HT, Tseng CL, Helou J, Ravi A, et al. Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy. Radiother Oncol. 2020 May 1;146:90 – 6. 23. van Son MJ, Peters M, Moerland MA, Lagendijk JJW, Eppinga WSC, Shah TT, et al. MRI-Guided Ultrafocal Salvage High-Dose-Rate Brachytherapy for Localized Radiorecurrent Prostate Cancer: Updated Results of 50 Patients. Int J Radiat Oncol Biol Phys. 2020 May 1;107(1):126 – 35. 24. Chitmanee P, Tsang Y, Tharmalingam H, Hamada M, Alonzi R, Ostler P, et al. Single-Dose Focal Salvage High Dose Rate Brachytherapy for Locally Recurrent Prostate Cancer. Clin Oncol R Coll Radiol G B. 2020 Apr;32(4):259 – 65. 25. Corkum MT, Mendez LC, Chin J, D’Souza D, Boldt RG, Bauman GS. A Novel Salvage Option for Local Failure in Prostate Cancer, Reirradiation Using External Beam or Stereotactic Radiation Therapy: Systematic Review and Meta Analysis. Adv Radiat Oncol. 2020 Sep 1;5(5):965 – 77.